Incidence of Second Primaries and Recurrent Disease in Early-Stage Lung Cancer: What Can We Expect in a Nodule-Care Center Cohort?
Our findings demonstrate that in a patient cohort undergoing NB for peripheral pulmonary nodules, 40.4% had SPLC or recurrent disease. Most of these patients had metachronous SPLC, underlining the need to obtain adequate tissue that allows for molecular analysis. In newly diagnosed lung cancer patients 22% needed new procedures which impact the need for healthcare facilities.
Authors
- Ad F. T. M. Verhagen (ORCID: https://orcid.org/0000-0003-0852-9681)
- Shoko Vos (ORCID: https://orcid.org/0000-0001-9012-5146)
- Erik H.J.G. Aarntzen (ORCID: https://orcid.org/0000-0002-3809-0182)
- E.H.F.M. van der Heijden
- Roel L.J. Verhoeven
- Desi K.M. ter Woerds
Institutions
- University Medical Center Groningen (NL)
- Radboud University Nijmegen (NL)
- Radboud University Medical Center (NL)
Publication Details
- Journal
- Respiration
- Published
- 2026-01-19
- DOI
- https://doi.org/10.1159/000550310
- Primary Topic
- Lung Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00